Differential tumor immune microenvironment coupled with tumor progression or tumor eradication in HPV-antigen expressing squamous cell carcinoma (SCC) models.

Autor: Shivarudrappa AH; University of Pittsburgh Medical Center UPMC Hillman Cancer Center, Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States., John J; University of Pittsburgh Medical Center UPMC Hillman Cancer Center, Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States., Vashisht M; University of Pittsburgh Medical Center UPMC Hillman Cancer Center, Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States., Ge H; University of Pittsburgh Medical Center UPMC Hillman Cancer Center, Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States., Liu S; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States., Chen J; University of Pittsburgh Medical Center UPMC Hillman Cancer Center, Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States., Siddoway K; University of Pittsburgh Medical Center UPMC Hillman Cancer Center, Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States., Dong R; University of Pittsburgh Medical Center UPMC Hillman Cancer Center, Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.; School of Medicine, Tsinghua University, Beijing, China., Chen Z; University of Pittsburgh Medical Center UPMC Hillman Cancer Center, Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States., Wang JH; University of Pittsburgh Medical Center UPMC Hillman Cancer Center, Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Jul 11; Vol. 15, pp. 1405318. Date of Electronic Publication: 2024 Jul 11 (Print Publication: 2024).

Lutein reverses hyperglycemia-mediated blockage of Nrf2 translocation by modulating the activation of intracellular protein kinases in retinal pigment epithelial (ARPE-19) cells.

Autor: Shivarudrappa AH; Department of Molecular Nutrition, CSIR-Central Food Technological Research Institute (CFTRI), Mysore, Karnataka, 570 020, India.; Academy of Scientific and Innovative Research (AcSIR), Gazhiabad, 201 002, India., Ponesakki G; Department of Molecular Nutrition, CSIR-Central Food Technological Research Institute (CFTRI), Mysore, Karnataka, 570 020, India. ganesanp@cftri.res.in.; Academy of Scientific and Innovative Research (AcSIR), Gazhiabad, 201 002, India. ganesanp@cftri.res.in.; Department of Biochemistry and Biotechnology, CSIR-Central Leather Resaerch Institute (CLRI), Adyar, Chennai, 600 020, India. ganesanp@cftri.res.in.

Publikováno v: Journal of cell communication and signaling [J Cell Commun Signal] 2020 Jun; Vol. 14 (2), pp. 207-221. Date of Electronic Publication: 2019 Dec 09.